Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
Positive results for zoliflodacin, EMA approval for fexinidazole and Merck cuts rotavirus commitment – take a look a the month’s industry headlines.
Glenn Tillotson gives us an overview of the CDiff Foundation’s 6th annual educational meeting, including updates on new C. difficile IDSA/SHEA clinical guidelines and patient perspectives.
In this infographic we take a look at the estimated burden of healthcare-associated infections in acute care hospitals across Europe.
We look at some of the highlights of our Twitter chat (#TalkFungi), where we questioned Ilan Schwartz, Andrej Spec, Rebecca Drummond and Jessie Uehling about all things mycology.
Join us for our Twitter chat with experts in the field on the 2 October at 15:00 BST/ 10:00 EDT, discussing fungal diseases, their burden and the challenges that face them #TalkFungi.
We take a look at the drugs that have been studied as treatments for confirmed prion diseases in humans – either in clinical trials, or on a compassionate, case-by-case basis – and look at what the future might hold for the treatment of prion diseases.
Glenn Tillotson gives us an overview of the 14th Biennial Congress of the Anaerobe Society of the Americas, including updates on the microbiome and new therapies.